Amended Statement of Beneficial Ownership (3/a)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Engelson Erik T.	2. Date of Event Requiring Statement (MM/DD/YYYY) 2/4/2021	3. Issuer Name and Ticker or Trading Symbol Lucira Health, Inc. [LHDX]
(Last)        (First)        (Middle) 1412 62ND STREET	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) President and Chief Executive /
(Street) EMERYVILLE, CA 94608       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY) 2/4/2021	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Preferred Stock	(1)	(1)	Common Stock	48854 (2)	(1)	I	See footnote (3)

Explanation of Responses:
(1)	Each share of Series B Preferred Stock (the "Preferred Stock") automatically converts on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock have no expiration date.
(2)	These shares were inadvertently omitted from the Reporting Person's original Form 3, and also were omitted from two Forms 4 filed by the Reporting Person after his original Form 3 was filed.
(3)	The shares are held by Epic Pacific, LLC, of which Reporting Person is a Member.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Engelson Erik T. 1412 62ND STREET EMERYVILLE, CA 94608	X		President and Chief Executive

Signatures
/s/ Dan George, Attorney-in-Fact for Erik T. Engelson		3/25/2021
**Signature of Reporting Person		Date